| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00 |
| filingDate |
1969-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10cfc7f3af358942952cc4bbb3a38389 |
| publicationDate |
1971-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-1941763-A1 |
| titleOfInvention |
3- (3-Oxo-11beta, 13beta-dialkyl-17beta-hydroxy-gon-, 4-en-17alphayl) -propionic acid-gamma-lactones |
| abstract |
Steroids of the formula: (I) There is a DELTA4(5) or DELTA5(10) double bond present. R and R' are each lower alkyl. (I) are potent progestational agents lacking sodium-excreting side effects. 3-(3-Oxo-11beta-methyl-17beta-hydroxyestr-4-en-17alpha-yl)-propio- nic acid gamma-lactone and the corresponding DELTA5(10)-cpd. |
| priorityDate |
1969-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |